Omeprazole micro-tablet capsule preparation and preparation method thereof
A technology of omeprazole microtablets and capsules, which is applied in the field of pharmaceutical preparations, can solve the problems of affecting the acid environment in the body, affecting the controlled release effect of hypertension drugs, and blood pressure fluctuations, and achieves simple and convenient preparation methods, reduced impact, and acid environment smooth effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0060]Embodiment 1: This preparation consists of the following components (unit: g / 1000 grains)
[0061] a. Tablet core prescription
[0062]
[0063] b. Coating prescription for controlled release layer
[0064] Hypromellose 13.5
[0065] Propylene Glycol 1
[0066] c. Immediate release layer coating prescription
[0067] Omeprazole 11
[0068] PVP K30 7
[0069] Dibutyl ester 1
[0070] d. Isolation layer coating prescription
[0071] Hypromellose 3.5
[0072] e. Enteric layer coating prescription
[0073] Methacrylic acid copolymer L30D-55 34
[0074] Diethyl phthalate 1.5
[0075] Concrete preparation steps are as follows:
[0076] 1) Preparation of tablet core: Omeprazole, sodium hydroxymethylcellulose, magnesium stearate, hydrogenated castor oil, microcrystalline fiber Preparing tablet cores with a diameter of 1-3 mm from plain element and methyl cellulose;
[0077] 2) Controlled-release layer coating: add hypromellose, propylene glycol, stearic acid, and...
example 2
[0082] Example 2: This preparation consists of the following components (unit: g / 1000 grains)
[0083] a. Tablet core prescription
[0084]
[0085] b. Coating prescription for controlled release layer
[0086] Eudragit RS 12
[0087] Eudragit E 1.5
[0088] Diethyl phthalate 1
[0089] c. Immediate release layer coating prescription
[0090] Omeprazole 5
[0091] PVP K30 9
[0092] Propylene glycol 0.5
[0093] d. Isolation layer coating prescription
[0094] PVP S630 6
[0095] e. Enteric layer coating prescription
[0096] Methacrylic acid copolymer L30D-55 31
[0097] Triethyl citrate 1.5
[0098] Concrete preparation steps are as follows:
[0099] 1) Preparation of tablet core: Omeprazole, sodium carboxymethylcellulose, stearic acid, magnesium stearate, pregelatinized The mixture of starch and methyl cellulose is prepared into a tablet core with a diameter of 1-3 mm;
[0100] 2) Controlled-release layer coating: Add Eudragit RS, Eudragit E, and diethyl ph...
Embodiment 3
[0105] Embodiment 3: This preparation consists of the following components (unit: g / 1000 grains)
[0106] a. Tablet core prescription
[0107]
[0108] b. Coating prescription for controlled release layer
[0109] PVP K30 18
[0110] Polyethylene glycol 1.5
[0111] c. Immediate release layer coating prescription
[0112] Omeprazole 14
[0113] HPMC 8
[0114] Polyethylene glycol 0.5
[0115] d. Isolation layer coating prescription
[0116] PVP K30 3
[0117] e. Enteric layer coating prescription
[0118] Methacrylic acid copolymer L30D-55 30
[0119] Propylene Glycol 2
[0120] Concrete preparation steps are as follows:
[0121] 1) Preparation of tablet core: Omeprazole, hypromellose, hydrogenated castor oil, stearic acid, microcrystalline cellulose and The mixture of PVP S630, magnesium stearate and micro silica gel is prepared into tablet cores with a diameter of 1-3mm;
[0122] 2) Coating of controlled release layer: add PVP K30, polyethylene glycol, steari...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 